MARKET

FBRX

FBRX

Forte Biosciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.25
+0.33
+1.74%
Closed 16:00 08/05 EDT
OPEN
19.37
PREV CLOSE
18.92
HIGH
21.04
LOW
18.75
VOLUME
28.04K
TURNOVER
--
52 WEEK HIGH
81.00
52 WEEK LOW
6.33
MARKET CAP
207.89M
P/E (TTM)
-0.0360
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average FBRX stock price target is 37.50 with a high estimate of 60.00 and a low estimate of 15.00.

EPS

FBRX News

More
Forte Biosciences, Inc. to Announce Second Quarter 2020 Results on August 10
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today that it will release second quarter 2020 results after the market close on Monday, August 10, 2020 and host a conference call at 4:30 p.m.
Business Wire · 3d ago
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.
Business Wire · 07/28 12:30
Forte Biosciences 13D Filing From CEO Paul Wagner Shows 21.04% Stake In Co.
Benzinga · 06/25 20:20
Ladenburg Thalmann Initiates Coverage On Forte Biosciences with Buy Rating
Ladenburg Thalmann initiates coverage on Forte Biosciences (NASDAQ:FBRX) with a Buy rating.
Benzinga · 06/22 11:10
Forte Biosciences, Inc. Announces Issuance of New U.S. Patent
FORTE BIOSCIENCES, INC. ANNOUNCES ISSUANCE OF NEW U.S. PATENT
Business Wire · 06/18 12:30
Tocagen Announces Change to Virtual Format for Special Meeting of Stockholders
PR Newswire · 05/28 21:05
Tocagen Q1 EPS $(0.430) Up From $(0.740) YoY
Tocagen (NASDAQ:TOCA) reported quarterly losses of $(0.430) per share. This is a 41.89 percent increase over losses of $(0.740) per share from the same period last year.
Benzinga · 04/23 20:06
108 Biggest Movers From Yesterday
Gainers
Benzinga · 03/11 09:34

Industry

Biotechnology & Medical Research
+0.18%
Pharmaceuticals & Medical Research
+0.35%

Hot Stocks

Symbol
Price
%Change

About FBRX

Forte Biosciences, Inc., formerly Tocagen Inc., is a clinical-stage biopharmaceutical company. The Company is focused on clinical program and developing a live biotherapeutic for the treatment of inflammatory skin diseases, particularly for pediatric atopic dermatitis patients. It provides FB-401, which is a live biotherapeutic for the treatment of inflammatory skin diseases. FB-401 has completed Phase I/II a testing in adult and pediatric patients with atopic dermatitis.
More

Webull offers kinds of Forte Biosciences Inc stock information, including NASDAQ:FBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FBRX stock methods without spending real money on the virtual paper trading platform.